Nader M. Habashi, MD, FACP, FCCP Investiture Program

NADER M. HABASHI, MD, FACP, FCCP
Nader M. Habashi, MD, FACP, FCCP is a
Professor of Medicine at the University of Maryland
School of Medicine and Critical Care Intensivist at
the R Adams Cowley Shock Trauma Center (STC).
In addition, Dr. Habashi serves as the Medical
Director for the Infinite Legacy Foundation Organ
Procurement Organization serving the Baltimore /
Washington, DC Donor Service Area.
Dr. Habashi completed fellowships in critical care
medicine and pulmonary medicine, including time
spent in Monza and Milan, Italy studying
extracorporeal carbon dioxide removal (ECCO2R)
techniques for respiratory failure. Although
previously thought to be contraindicated in trauma
patients, Dr. Habashi initiated the first extracorporeal
oxygenation (ECMO) program at STC in 1992. Subsequently, Dr. Habashi’s focus turned to
a mode of ventilation called airway pressure release ventilation (APRV) where he developed
and refined a method of personalizing APRV to each patient, enabling the decreased need
for ECMO. During the 2019 COVID outbreak, he received the attention of the Department
of Defense for his expertise in mechanical ventilation and was asked to collaborate with
defense contractors Northrop Grumman and L3 Harris, as well as the Johns Hopkins
Applied Physics Lab, to expedite the development of ventilators that could be mass
produced and used during outbreaks. Dr. Habashi also facilitated the delivery of ventilators
to areas with the heaviest burden from COVID such as New York City, NY and Milan, Italy.
At the onset of the COVID outbreak, because of the uncertainty about how to help these
patients, Dr. Habashi volunteered to work in the Bio-containment unit at STC with a desire
to learn and understand more about COVID. Further, Dr Habashi supported physician
colleagues worldwide who were struggling with COVID and desperate to help patients that
were failing traditional approaches.
Dr. Habashi’s research continues to evolve and centers on understanding lung
micromechanics and the concept that lung injury in acute respiratory failure shares
similarities with chronic progressive lung diseases. Acute lung injury develops
characteristics of chronic lung disease over a shorter time course, thereby providing a model
to study the continuum of lung diseases. The accelerated evolution of acute lung disease
transition to features of chronic lung disease may hasten our understanding and gain insights
to a spectrum of lung diseases that have traditionally been conceptually isolated.
Dr. Habashi collaborates with Professor Gary Neiman at the Upstate Medical University in
Syracuse, New York using large animal models of lung injury to prevent acute respiratory
distress syndrome (ARDS) progression. In addition, Dr. Habashi collaborates with Dr.
Jason Bates at the University of Vermont and Dr. Don Gaver of Tulane University to better
understand the lung through computational modeling of lung injury. Supporting the failing
lung has led Dr. Habashi and his colleagues to discover and publish extensively on
preemptive techniques which can be used to prevent and halt progressive forms of lung
injury and disease creating opportunities to improve therapeutic options and develop new
treatment strategies applicable to all forms of lung disease. Internationally, Dr. Habashi
works closely with Dr. Luigi Camporota at Kings College in London in the United
Kingdom, who was recently awarded a grant from the National Institute of Health Research
(NIHR) to conduct a multicenter UK trial comparing APRV to standard of care ventilation
in the treatment of acute respiratory failure. Dr. Habashi will serve as a consultant for the
trial which will use a method of APRV that he developed and refined.

WELCOME
Heather S. Culp, JD
Senior Vice President
Chief Philanthropy Officer
University of Maryland Medicine
Thomas M. Scalea, MD
The Honorable Francis X. Kelly Distinguished Professor of Trauma Surgery
Director, Program in Trauma
University of Maryland School of Medicine
Physician-in-Chief, R Adams Cowley Shock Trauma Center
System Chief for Critical Care Services, University of Maryland Medical System
REMARKS
Mark T. Gladwin, MD
Dean, University of Maryland School of Medicine
Vice President for Medical Affairs, University of Maryland, Baltimore
John Z. and Akiko K. Bowers Distinguished Professor
DONOR RECOGNITION
Mark T. Gladwin, MD
SPEAKERS
Jason H. T. Bates, PhD, DSc
Professor of Medicine, Molecular Physiology & Biophysics and
Electrical & Biomedical Engineering
University of Vermont
Gary Nieman
Professor of Research, Department of Surgery
Upstate Medical University
Syracuse, New York
Kevin K. Chung, MD, FCCM, MACP
Chief Medical Officer
SeaStar Medical
MEDAL PRESENTATION
Mark T. Gladwin, MD
REMARKS
Nader M. Habashi, MD, FACP, FCCP
The Hamish S. and Christine C. Osborne Distinguished Professor
in Advanced Pulmonary Care
CLOSING REMARKS
Thomas M. Scalea, MD

T
he first endowed professorships were established more than 500
years ago with the creation of the Lady Margaret chairs in divinity
at Oxford and Cambridge Universities. The original endowed
chairs were sponsored by Lady Margaret, countess of Richmond,
and grandmother of Henry VIII in 1502. Subsequently, private individuals
began making financial contributions to establish other endowed
professorships and chairs such as the Lucasian Chair of Mathematics, which
Sir Isaac Newton held beginning in 1669. Professor Stephen Hawking, the
internationally renowned physicist and recipient of the 2010 Presidential
Medal of Freedom, was another prominent holder of this endowed chair.
The honor associated with appointment to an endowed position has remained
unchanged for the last 500 years and is recognized as one of the highest
tributes that an academic institution can bestow upon its most distinguished
faculty. These endowed professorships and chairs continue to reward
exceptional scholars uninterrupted to the present time.
The Office of Development is charged with securing private gifts to ensure the
School’s tradition of excellence is sustained through robust research, clinical,
and educational programs and initiatives. The University of Maryland School
of Medicine is fortunate to have nearly 85 endowed chairs & professorships in
various stages of completion and held by esteemed faculty members.

HAMISH S. OSBORNE AND
CHRISTINE C. OSBORNE
Christine C. and Hamish S. Osborne moved to
Baltimore in 1969, after attending the University
of Arizona. Hamish worked for both the Social
Security Administration and the Maryland
Department of Health and Human Services
before enrolling at the University of Maryland
School of Law. Christy continued her studies in
Art History at Goucher College and became a
docent at the Walters Art Gallery. Hamish
served as editor of the Maryland Law Review,
then worked for a partnership in Howard County
before entering private practice. During this time, Hamish was active in
Leadership Howard County. He also served as a trustee for McDonogh
School during the transformation of the school’s physical plant in the
1990’s.
As community-oriented philanthropists, the Osbornes sought unmet needs in
academic settings, establishing a series of unique scholarships for low- and
middle-income students at McDonogh School and Maryland Law. For
decades, these endowments have provided life-changing opportunities for
generations of Baltimore-area scholars. Hamish volunteered on twelve
boards, including hospitals, military organizations, community foundations
and the Board of Visitors at the Carey School of Law.
In the mid-90’s Hamish began exhibiting symptoms of lung disease,
including evidence of scaring, which was later diagnosed as Pulmonary
Fibrosis. On January 19, 2013, at the age of 64, Hamish became a grateful
recipient of a lung transplant at the University of Maryland Medical Center.
Thanks to the miracle of lung transplantation, and excellent care from the
medical staff at UMMC, Hamish had three additional years with Christy,
their three children, and twelve grandchildren. Christy and Hamish were
married for 47 years when Hamish passed away at this hospital on July 30,
2016. He had just turned 67.
While Hamish was treated at Maryland, the Osbornes established this
Distinguished Professorship in Advanced Pulmonary Care, in the hopes of
alleviating suffering for those facing lung disease.